View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Analysis
January 14, 2022updated 17 Jan 2022 9:01am

Asia-Pacific has seen the largest growth in oncology-related trials over the past decade

We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.

By Saywah Mahmood

The Asia-Pacific region has seen a 138% increase in the number of oncology trials taking place over the past decade, the largest increase for any region worldwide.

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

The region now ranks in first for the total number of trials taking place, compared to its second-placed ranking in 2010.

These figures come from GlobalData’s extensive clinical trials database which seeks to track the number of clinical trials taking place in countries around the world, in numerous therapy areas.

Asia-Pacific

The Asia-Pacific region saw the biggest increase in oncology related trials.

Between 2010 and 2020, there was a 138% increase in the number of trials taking place.

In 2020, the largest proportion of trials in the region took place in China with 58.1% of all trials in the region taking place there.

Japan and South Korea had the next largest percentage of trials taking place in the region with 9.9% and 8.6%, respectively.

Middle East

The Middle East saw a 94% increase in the number of oncology trials taking place.

Israel saw the largest amount of trials taking place, in 2020, at 62.5%.

Trials in Iran and Saudi Arabia also made up a large proportion of the trials taking place with 27.7% and 3.8%, respectively.

South and Central America

South and Central America saw a 58% increase in the number trials taking place.

Brazil, Argentina and Chile made up the most trials in the region, with 41.1%, 23.3% and 12.3%, respectively.

Europe

Europe saw a 28% increase in oncology related trials taking place.

France saw the largest percentage of trials taking place in the region at 10.9%.

Spain and Germany also made up a significant proportion of the trials taking place.

Africa

Despite being placed fifth, Africa still saw an increase in the number of oncology trials.

The region saw a 26% increase in the number of trials.

Egypt made up 51.2% the largest proportion of trials taking place in the region.

South Africa and Eswatini also made up a large amount of the trials taking place with 44.2% and 2.3%, respectively.

North America

North America saw the biggest decrease in oncology trials.

The number of trials in the region fell by 13% between 2010 and 2020.

The United States saw the largest percentage of trials taking place in the region with 83.9%.

Mexico saw the fewest trials taking place in the region at 3%.

Related Companies

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology